CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 15 enrolled
Drug / intervention
Ketamine infusion +1 moredrug
Likely dose
Ketamine infusion 0.5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01100255
NCT01100255Phase 2Completed
CompareCT.gov

Understanding the Glutamate System in Adults With Obsessive-Compulsive Disorder With N-methyl-D Aspartate Antagonist Ketamine

New York State Psychiatric Institute·interventional·Posted Apr 8, 2010·Updated Feb 20, 2017

In Brief

A Phase 2 clinical trial evaluating Ketamine infusion and Saline for Obsessive-Compulsive Disorder. Completed, enrolled 15 participants across 1 site.

Detailed Summary

In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive-Compulsive Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 8, 2010
Enrollment StartApr 1, 2010
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 16.2 years ago

Interventions

Ketamine infusiondrug

0.5mg/kg IV over 40 minutes

Salineother

saline infusion